BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38160431)

  • 1. A machine learning model to predict therapeutic inertia in type 2 diabetes using electronic health record data.
    McDaniel CC; Lo-Ciganic WH; Huang J; Chou C
    J Endocrinol Invest; 2024 Jun; 47(6):1419-1433. PubMed ID: 38160431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-related complications, glycemic levels, and healthcare utilization outcomes after therapeutic inertia in type 2 diabetes mellitus.
    McDaniel CC; Lo-Ciganic WH; Chou C
    Prim Care Diabetes; 2024 Apr; 18(2):188-195. PubMed ID: 38185576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting short- and long-term glycated haemoglobin response after insulin initiation in patients with type 2 diabetes mellitus using machine-learning algorithms.
    Nagaraj SB; Sidorenkov G; van Boven JFM; Denig P
    Diabetes Obes Metab; 2019 Dec; 21(12):2704-2711. PubMed ID: 31453664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
    Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
    J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
    Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
    Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
    Ampudia-Blasco FJ; Palanca A; Trillo JL; Navarro J; Real JT
    J Diabetes Complications; 2021 Mar; 35(3):107828. PubMed ID: 33436143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes.
    Musacchio N; Zilich R; Ponzani P; Guaita G; Giorda C; Heidbreder R; Santin P; Di Cianni G
    J Diabetes; 2023 Mar; 15(3):224-236. PubMed ID: 36889912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.
    Lo-Ciganic WH; Huang JL; Zhang HH; Weiss JC; Wu Y; Kwoh CK; Donohue JM; Cochran G; Gordon AJ; Malone DC; Kuza CC; Gellad WF
    JAMA Netw Open; 2019 Mar; 2(3):e190968. PubMed ID: 30901048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study.
    Wan KS; Moy FM; Mohd Yusof K; Mustapha FI; Mohd Ali Z; Hairi NN
    PLoS One; 2020; 15(10):e0240531. PubMed ID: 33035261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43).
    Satoh J; Andersen M; Bekker Hansen B; Larsen Thorsted B; Tutkunkardas D; Zacho M; Maegawa H
    PLoS One; 2018; 13(9):e0198160. PubMed ID: 30226870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification patterns and the probability of HbA
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman JM; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
    Diabet Med; 2020 Jul; 37(7):1114-1124. PubMed ID: 30653705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
    Ali SN; Dang-Tan T; Valentine WJ; Hansen BB
    Adv Ther; 2020 Feb; 37(2):869-882. PubMed ID: 31925649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
    González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
    Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA.
    Rattelman CR; Ciemins EL; Stempniewicz N; Mocarski M; Ganguly R; Cuddeback JK
    Diabetes Ther; 2021 Feb; 12(2):581-594. PubMed ID: 33460018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy.
    Kartoun U; Iglay K; Shankar RR; Beam A; Radican L; Chatterjee A; Pai JK; Shaw S
    Curr Med Res Opin; 2019 Dec; 35(12):2063-2070. PubMed ID: 31337263
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and Validation of a Machine Learning Model Using Administrative Health Data to Predict Onset of Type 2 Diabetes.
    Ravaut M; Harish V; Sadeghi H; Leung KK; Volkovs M; Kornas K; Watson T; Poutanen T; Rosella LC
    JAMA Netw Open; 2021 May; 4(5):e2111315. PubMed ID: 34032855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.